Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Journal of Neurophysiology|March 30, 2007
Direct inhibition of Ih by analgesic loperamide in rat DRG neuronsDmitry V Vasilyev, Qin Shan, Yan Lee, et al.
Journal of Biomolecular Screening|September 24, 2009
A novel high-throughput screening assay for HCN channel blocker using membrane potential-sensitive dye and FLIPRDmitry V Vasilyev, Qin J Shan, Yan T Lee, et al.
Learning & Memory (Cold Spring Harbor, N.Y.)|February 19, 2009
The role of calsenilin/DREAM/KChIP3 in contextual fear conditioningJon C Alexander, Carmel M McDermott, Tumay Tunur, et al.
Bioorganic & Medicinal Chemistry|August 6, 2005
Identification and characterization of small molecule modulators of KChIP/Kv4 functionMark R Bowlby, Pranab Chanda, Wade Edris, et al.
Molecular Pharmacology|March 13, 2010
Genetic and functional analysis of human P2X5 reveals a distinct pattern of exon 10 polymorphism with predominant expression of the nonfunctional receptor isoformSmita Kotnis, Brendan Bingham, Dmitry V Vasilyev, et al.
Bioorganic & Medicinal Chemistry|January 30, 2008
Disruption of Kv1.1 N-type inactivation by novel small molecule inhibitors (disinactivators)Qiang Lu, Joseph Peevey, Flora Jow, et al.
Assay and Drug Development Technologies|May 18, 2010
Ion channel screening plates: design, construction, and maintenanceScott C Mayer, John A Butera, David J Diller, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 4, 2008
Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide)John Dunlop, Tim Lock, Brian Jow, et al.
Neurobiology of Disease|July 9, 2008
Amiloride is neuroprotective in an MPTP model of Parkinson's diseaseRobert L Arias, Mei-Li A Sung, Dmytro Vasylyev, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 1, 2013
Quantitative electroencephalography within sleep/wake states differentiates GABAA modulators eszopiclone and zolpidem from dual orexin receptor antagonists in ratsSteven V Fox, Anthony L Gotter, Spencer J Tye, et al.
Pageof 3